[Latin Name] Glycine max(L.) Mere

[Specification] 90%; 95%

[Appearance] White powder

[Melting point] 134-142℃

[Particle size] 80Mesh

[Loss on drying] ≤2.0%

[Heavy Metal] ≤10PPM

[Storage] Store in cool & dry area, keep away from the direct light and heat.

[Shelf life] 24 Months

[Package] Packed in paper-drums and two plastic-bags inside.

[Net weight] 25kgs/drum

[What is Phytosterol?]

Phytosterols are compounds found in plants that resemble cholesterol. The National Institutes of Heath report that there are over 200 different phytosterols, and the highest concentrations of phytosterols are found naturally in vegetable oils, beans and nuts. Their benefits are so recognized that foods are being fortified with phytosterols. At the supermarket, you may see orange juice or margarine advertising phytosterol contents. After reviewing the health benefits, you may want to add phytosterol-rich foods to your diet.

[Benefits]

Cholesterol-Lowering Benefits

The most well-known, and scientifically proven, benefit of phytosterols is their ability to help lower cholesterol. A phytosterol is a plant compound that is similar to cholesterol. A study in the 2002 issue of “Annual Review of Nutrition” explains that phytosterols actually compete for absorption with cholesterol in the digestive tract. While they prevent the absorption of regular dietary cholesterol, they themselves are not easily absorbed, which leads to a total lower cholesterol level. The cholesterol-lowering benefit does not end with a good number on your blood work report. Having lower cholesterol leads to other benefits, such as a reduced risk for heart disease, stroke and heart attacks.

Cancer Protection Benefits

Phytosterols have also been found to help protect against the development of cancer. The July 2009 issue of the” European Journal of Clinical Nutrition” offers encouraging news in the fight against cancer. Researchers at the University of Manitoba in Canada report that there is evidence that phytosterols help prevent ovarian, breast, stomach and lung cancer. Phytosterols do this by preventing the production of cancer cells, stopping the growth and spread of cells that are already in existence and actually encouraging the death of cancer cells. Their high anti-oxidant levels are believed to be one way phytosterols help fight cancer. An anti-oxidant is a compound that fights free radical damage, which is negative effects on the body produced by cells that are unhealthy.

Skin Protection Benefits

A lesser known benefit of phytosterols involves skin care. One of the contributing factors in the aging of the skin is the breakdown and loss of collagen — the main component in connective skin tissue — and sun exposure is a major contributor to the problem. As the body ages, it is not able to produce collagen as it once did. The German medical journal “Der Hautarzt” reports a study in which various topical preparations were tested on skin for 10 days. The topical treatment that showed anti-aging benefits to the skin was the one that contained phytosterols and other natural fats. It is reported that phytosterols not only stopped the slow-down of collagen production that can be caused by the sun, it actually encouraged new collagen production.

Fayed, A.E.
Detection of Domiati cheese adultration with palm oil.
Identification of palm oil in some fatty products.
Influence of insecticide residues on growth and activity of Streptococcus diacetilactis and Leuconostoc cremoris.
Presistence of Fenvalerate pyrethroid in milk in relation to lactic acid bacteria.
Susceptibility of some lactic acid bacteria to different insecticides.
Ultrafiltration of reconstituted skimmilk powder in relation to the rennet ability and casein fractions.
Application of ultrafiltration technique for production of low calorie recombined butter rich in protein.
Ultrafiltration whey protein concentrate as a substitute for egg white in pie topping meringue.
Production of aromatic recombined butter by using different milk solids not fat ingredients.
Distribution of some insecticides in milk fat globule materials.
Keeping quality of market butter oil in comparison with samna.
Ultrafiltration whey concentrate as protein fortifier in macaroni manufacture from wheat flour.
Fiber fortification of ice milk by means of cooked wheat.
Enhancement of milk fat quality by conversion into recombined butter in relation to some properties of skimmilk powder used.
Incidence of some environmental pollutants in milk and its products at great Cairo markets.
Substitution of non fat milk solids in ice cream with ultrafiltration whey protein concentrate.
Milk preparedness for bacterial growing in relation to environmental contaminants.
Quality evaluation of imported skimmilk prowder.
Effect of milk fat quality on the properties of recombined butter.
Utilization of some food industry wastes prepared as milk fat antioxidants.
Effect of microwave treatment on bacteriological and keeping quality of buffaloes milk.
Monitoring some contaminants during the manufacture of some conventional dairy products.
Ultrafiltration membrance permeability of some milk contaminants.
Physical and organoleptic properties of yoghurt made from standardized buffalo’s milk fortified with total milk proteinate.
Production and characterization of bacterial coagulants as calf rennet replacer for Egyptian cheesemaking.
The profile of market Domiati cheese with emphasis on biogenic amines occurrence.
Production of bacteriocin using ultrafiltrated milk permeate.
The use of ultrafiltration technique for recovery of nisin-like bacteriocin.
Comparative supplementation of ice cream mixes by ultrafiltrated skimmilk retentate or whey proteins concentrate.
Production of low calorie ice cream.
Comparative acylation methods of ultrafiltrated whey proteins concentrate with emphasis on the functional properties.
Effect of using alternative combination of glucono delta lactone with lactic starter culture on the properties of UF-white soft cheese during cold storage.
Brevibacterium linens as an adjunct starter culture in low fat Ras cheese.
Influence of some preservatives on cast UF-white soft cheese properties during cold storage.
Antifungal efficiency of a starter culture containing Lactobacillus reutrei during Ras cheese ripening.
Influence of formaldehyde and hydrogen peroxide as preservatives on the properties of buffalo’s milk proteins.
Comparative evaluation between Selandid and Maltodextrin as fat mimetic in low fat Ras cheesemaking.
Production of probiotic low calorie sour cream.
Production of light calorie whipped cream using mimetic fats and stevioside.
Effect of Transglutaminase on the quality of yoghurt made with different milk protein sources.
Biological evaluation of cow’s milk yoghurt fortified with different source of milk proteins.
Antifungal efficiency of a starter culture containing some Lactobacillus species during Ras cheese ripening.
Utilization of ultrafiltrated whey protein concentrate in the manufacture of reduced fat processed cheese spread.
Biological Attributes of bio-yoghurt versus the conventional one fed in spray dried form.
Effect of cow’s milk treatment with transglutaminase on the composition and quality of yoghurt with particular reference to its biological value.
Performance of transglutaminase as body stabilizer in Tallaga cheese made from ultrafiltrated cow’s milk retentate.
Utilization of mushroom powder for substituting dried skimmilk in the manufacture of processed cheese spread.
Glycoprotein fortification of bioyoghurt.
Improvement of yoghurt efficiency as functional food by glycoprotein fortification.
Application of ultrafiltration technique in the manufacture of reduced-calorie frozen bioyoghurt in synbiotic form.
Healthy multifunctional spectra of milk glycoproteins and their fragments.
Production of carbonated stirred yoghurt fortified with some physiological active ingredients.
Physiologically Active Ingredients as Yoghurt Fortifiers.
Rheological, microstructural and biological characteristics of probiotic ultrafiltrated skimmed milk cheese in comparison with the conventional Kariesh cheese.
Economics scale for processing of white soft cheese in Egypt.

Title: Pneumococcal infections and vaccination.
4th International Conference on Vaccines & Vaccination
September 24-26, 2014 Valencia, Spain

OMICS International: https://omicsonline.org
Vaccine Conferences: https://conferenceseries.com/immunolog…
Global Medical Conferences: https://conferenceseries.com
Global Pharmaceutical Conferences: https://pharmaceuticalconferences.com
Global Cancer Conferences: https://cancersummit.org
Global Diabetes Conferences: https://diabetesexpo.com
Global Dental Conferences: https://dentalcongress.com
Global Nursing Conferences: https://nursingconference.com

Abstract
Pneumococci are major contributors to morbidity and mortality worldwide. They are the major cause of milder respiratory tract infections such as otitis and sinusitis, but also to more severe invasive infections such as community-acquired pneumonia with associated septicemia and meningitis. Even though being a devastating pathogen, pneumococci are also common colonizers of the upper respiratory tract of healthy children where from they may spread to cause disease. Risk groups for acquiring an invasive pneumococcal infection (IPD) include preschool children and the elderly, as well as immunocompromised individuals, splenectomised, and patients with a previous influenza virus infection. Several bacterial virulence factors have been described for pneumococci of which a major one is the capsular polysaccharide. Depending on differences in these capsular structures so far more than 90 different serotypes have been distinguished. Recently so called conjugated vaccines (PCV) have been introduced into the child hood vaccination program in many countries. These vaccines are based on a limited amount (7, 10 or 13) of the capsular serotypes. In Sweden PCVs were introduced in the whole of Sweden year 2009. Vaccine introduction has led to a reduction in the incidence of IPD in vaccinated children but also to serotype replacementand an increase of non-vaccine type disease.

Biography

Birgitta Henriques Normark is professor and head physician in Clinical microbiology at Karolinska Institute and Karolinska University hospital, as well as head physician at the Public Health Agency of Sweden. She is also vice dean for recruitment at Karolinska Institutet and a board member of the Swedish Research Council, Medicine and Health.Her research focuses on epidemiology, antibiotic resistance and host-microbe interactions in bacterial infections with special focus on pneumococcal epidemicity, molecular epidemiology, and mechanisms of invasive disease, innate immunity and host-microbe interactions determining disease outcome. The research has been published in 136 publications of which 107 are original peer reviewed articles.